Synageva BioPharma(TM) reports second quarter 2014 financial results
Synageva BioPharma(TM) reported a net loss of $50.2 million for the 20144 second quarter versus a net loss of $22.1 million for the corresponding quarter of the prior year, and revenue of $2.3 million for the quarter ended June 30, 2014. July 30, 2014